Radiation Safety Procedures For Non-Radiation Workers in Case of Application Radionuclide Therapy in the Dialysis Patients
暂无分享,去创建一个
M. Demir | A. Ayan | Bilal Kovan | S. Kıraç | Meral Değer | Nami Yeyin | F. Aras | B. Gunalp | K. Köseoğlu | Bağnu Uysal | Semra Dönmez | Mehmet İnce | Leyla Poyraz | İ. Özaslan | Türkay Toklu
[1] N. Mulholland,et al. 177Lu-Dotatate therapy for the treatment of metastatic neuroendocrine tumours in a patient on haemodialysis—dosimetric considerations , 2015, BJR case reports.
[2] M. Benghanem Gharbi,et al. [Management of iodine-131 ablation therapy for thyroid carcinoma in a patient on chronic hemodialysis]. , 2015, Nephrologie & therapeutique.
[3] M. Iori,et al. Radiation protection procedures in 131I treatments for thyroid cancer in patients requiring hemodialysis , 2014, Nuclear medicine communications.
[4] M. Tsai,et al. Safety of Ablative Radioiodine Therapy for Differentiated Thyroid Cancer in a Patient with End-Stage Renal Disease under Hemodialysis , 2013 .
[5] M. Alevizaki,et al. Iodine 131 treatment for differentiated thyroid carcinoma in patients with end stage renal failure: dosimetric, radiation safety, and practical considerations. , 2006, Hormones.
[6] I. Mcdougall,et al. Management of Thyroid Papillary Carcinoma With Radioiodine in a Patient With End Stage Renal Disease on Hemodialysis , 1994, Clinical nuclear medicine.
[7] N. Howard,et al. Iodine 131 ablation therapy for a patient on maintenance haemodialysis. , 1981, The British journal of radiology.
[8] D. Silverberg,et al. Effects of chronic hemodialysis on thyroid function in chronic renal failure. , 1973, Canadian Medical Association journal.